Enanta Hopes To Succeed In RSV With N-Protein Inhibition Approach

 
• By Joseph Haas
  
respiratory-syncytial-virus
Efforts to develop a drug therapy for RSV had yielded numerous failures
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D